Company news: Vibrant

Share this article:

Contextual advertising firm Vibrant reported 58% growth in pharmaceutical-related revenue in the third quarter. The firm, which said it manages more than six billion hyperlinks, works with brands across prescription and OTC pharmaceuticals in major health categories such as rheumatoid arthritis, hypertension, diabetes, depression, stroke and cholesterol, according to a press release. Vibrant's contextual ad model is designed to allow pharmaceutical marketers to deliver targeted ads and information within relevant, condition-specific web content, working to connect users with brands and relevant content from a network of 4,500 publishers.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.